SCHEMBL7328253

SCHEMBL7328253

Cc1cccc(CN(C[C@@H](O)CCc2ccccc2)N(NC(=O)OCc2ccccc2)C(=O)OC(C)(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.47
SLC1A5 Q15758 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
SYK P43405 1/20 0.39
LMNA P02545 2/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
HTT P42858 1/20 0.38
AKT1 P31749 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CTSS P25774 2/20 0.37
CTSK P43235 2/20 0.37
CTSL P07711 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8333233 0.91 BACE1 (0.44) BACE1SLC1A5SMN1; SMN2SYKLMNA
SCHEMBL7328963 0.90 BACE1 (0.44) BACE1SLC1A5SMN1; SMN2SYKLMNA
SCHEMBL7327200 0.87 BACE1 (0.41) BACE1SLC1A5SMN1; SMN2SYKLMNA
SCHEMBL7331893 0.86 BACE1 (0.44) BACE1SMN1; SMN2SYKLMNAMEN1
SCHEMBL7366418 0.86 BACE1 (0.44) BACE1SLC1A5SMN1; SMN2SYKLMNA
SCHEMBL8333205 0.86 SMN1; SMN2 (0.44) BACE1SMN1; SMN2SYKLMNAMAPT
SCHEMBL8333717 0.85 BACE1 (0.40) BACE1SMN1; SMN2SYKLMNAMEN1
SCHEMBL8331022 0.85 BACE1 (0.43) BACE1SMN1; SMN2SYKLMNAMAPT
SCHEMBL8469355 0.85 CYP3A4 (0.45) BACE1SLC1A5SMN1; SMN2SYKMAPT
SCHEMBL8334059 0.85 BACE1 (0.41) BACE1SMN1; SMN2SYKLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed
WO-1994019332-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-09-01 WO disclosed